Brainstem Dysfunction Involvement in the Pathogenesis of Pierre Robin Sequence (DYSROBIN)
Pierre Robin Sequence, Brainstem Dysfunction
About this trial
This is an interventional other trial for Pierre Robin Sequence focused on measuring Pierre Robin sequence, Brainstem, pathogenesis, swallowing, apnea
Eligibility Criteria
Inclusion Criteria for the group 1
- infants with PRS
Inclusion Criteria for the group 2 - infant with isolated airway obstruction
Inclusion Criteria for the group 3
- healthy infant : siblings of sudden unexpected death of the infant or with any known pathology
Inclusion Criteria for the 3 groups
- During one hospitalization or program for one hospitalization
- Parental consent
- Social safety affiliation
Exclusion Criteria:
- Birth before 37 SA
- Neonatal complication
- Group 2 only: AWO with neurological disease including brainstem dysfunction
- Group 3 only : AWO, ENT disease or syndromic disease, neurological disease including brainstem dysfunction, Intra uterine growth retardation
Sites / Locations
- Hopital Femme Mère EnfantRecruiting
- APHP-Necker
Arms of the Study
Arm 1
Arm 2
Arm 3
Other
Other
Other
Pierre Robin sequence
Superior airway obstruction, AWO
Healthy infants
Infants with PRS : retrognathism, glossoptosis, cleft palate Group 1a : isolated PRS Group 1b : PRS with bone disease or collagen disease (Stickler) Group 1c : syndromic PRS or associated PRS without bone disease or collagen disease
Infants with AWO : laryngomalacia, tracheal stenosis, laryngeal stenosis, others etiology
Healthy infants : siblings of sudden unexpected death of the infant